Close
Nordic 9Nordic 9

Sanofi Ventures (investor - Corporate Investor)

France sanofiventures.com
See something wrong or missing? Let us know
Offices:Paris

Sanofi Ventures is the corporate venture capital arm of Sanofi and invests in early-stage biotech and digital health companies with innovative ideas and transformative new projects of strategic interest to Sanofi.

  • in 2023, Sanofi Ventures said that its parent pharma company has made a $750 million, multi-year investment commitment to the group.
Average round investment:1.213B USD
Average number per year:2.5
Distribution: 2025 (4)2024 (2)2023 (2)2022 (4)2021 (2) See the entire list
Portfolio companies: United Kingdom VicebioUnited Kingdom Draig TherapeuticsSpain Splice Bio See the entire list
Mostly invests in: Denmark Denmark (4) Health services (14)
See the entire list

Showing 3 of 15 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Sanofi Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sanofi Ventures

Name Criteria
United Kingdom Schroders
91%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France, Switzerland
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United Kingdom Lightrock
91%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France, Italy
  • Average number of deals per year: 4.2
  • Active last 12 months: Yes
United States Meritech Capital Partners
90%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Software Services, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
China HSG Capital
90%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Norway Equinor Energy Ventures
90%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, United Kingdom, France, Spain
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Germany Siemens
90%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France, Switzerland
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
United States Goldman Sachs
89%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, United Kingdom, France, Spain, Switzerland
  • Average number of deals per year: 6.5
  • Active last 12 months: Yes
United States TPG
89%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark, United Kingdom, Italy, Spain
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Germany Hitachi Ventures
89%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, France, Switzerland
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United Kingdom M&G Investments
89%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Italy, Spain, Switzerland
  • Average number of deals per year: 5.0
  • Active last 12 months: Yes
Top